Madden Securities’s Elevance Health ELV Stock Holding History

Madden Securities’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-150	Closed	-$76.9K	–	175
2022 Q4	$76.9K	Buy	+150	New	+$76.2K	0.04%	158

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Madden Securities's ELV Position: Q1 2023 in Review

Madden Securities sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 150 shares — an estimated $76.9K sold.

Madden Securities first reported a position in ELV in Q4 2022 and held it in 1 quarter. The position peaked at $76.9K in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

Madden Securities reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
Madden Securities sold 150 Elevance Health shares in Q1 2023, an estimated $76.9K.
Madden Securities first reported a position in Elevance Health in Q4 2022 and held it in 1 quarter.
Madden Securities's Elevance Health position peaked at $76.9K in Q4 2022.
1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Madden Securities's 13F filing for Q1 2023, filed 21 Apr 2023.